IP Library Granted Patent US 7,863,427
Granted Patent B2
US 7,863,427 · App. 11/734,661 · Granted Jan 4, 2011

Immunoassays for buprenorphine and norbuprenorphine

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,863,427
App. No.
11/734,661
Granted
Jan 4, 2011
Kind
B2
Abstract

Methods, compositions and kits are disclosed directed at haptens, immunogens and immnoassays for buprenorphine (BUP) and nor buprenorphine (norBUP). The method comprises providing in combination in a medium (i) a sample suspected of containing buprenorphine (BUP) or norbuprenorphine (norBUP) and (ii) an antibody raised against an immunogen of buprenorphine (BUP) or norbuprenorphine (norBUP). The medium is examined for the presence of a complex comprising a labeled hapten of buprenorphine (BUP) or norbuprenorphine (norBUP) where the presence of such as complex indicates the presence of the compound in the sample.

Claims (7)

1. A compound of the formula 3:

wherein

R 1 is H; or protecting group, or glucuronide;

R 2 is —Y—Z, wherein Y is —C(O)(CH 2 ) n —, wherein n is an integer from 1 to 10, and including acid salts thereof and Z is haloacetamide;

R 3 is a t-butyl group;

R 4 is hydrogen; and

R 5 is a methyl group.

Assignments (1)
MERGER Recorded Jun 22, 2010
From: DADE BEHRING INC.
To: SIEMENS HEALTHCARE DIAGNOSTICS INC.
Reel/Frame 024576/0236 →